Clinical Trial Update: Cocaine Use Reduction With Buprenorphine [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial investigating buprenorphine for reducing cocaine use in cocaine dependence; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Dependence

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Cocaine Dependence | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-10-29